Antipsychotic Selection
Share
SaveShare this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Overview
Psychiatrists have been buzzing about the CATIE trial ever since results were first published in 2005. Most non-psychiatrists are unaware of its widespread implications. What have we learned about antipsychotic selection? University of Michigan’s Director of Psychiatry Residency Education, Michael Jibson, MD discusses evidence based antipsychotic selection with host Dr. Leslie Lundt.
Recommended
Details
Presenters
Overview
Psychiatrists have been buzzing about the CATIE trial ever since results were first published in 2005. Most non-psychiatrists are unaware of its widespread implications. What have we learned about antipsychotic selection? University of Michigan’s Director of Psychiatry Residency Education, Michael Jibson, MD discusses evidence based antipsychotic selection with host Dr. Leslie Lundt.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?